SHANGHAI PHARMACEUTICALS HOLDING CO revenue for the last year amounted to 292.96 B HKD, the most of which — 266.20 B HKD — came from its highest performing source at the moment, Distribution, the year earlier bringing 252.32 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI PHARMACEUTICALS HOLDING CO 292.98 B HKD, and the year before that — 282.84 B HKD.